Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|December 15, 2019
Acid Sphingomyelinase Deficiency Ameliorates Farber DiseaseNadine Beckmann, Katrin Anne Becker, Stephanie Kadow, et al.Journal of Lipid Research|March 12, 2020
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitroEyad Naser, Stephanie Kadow, Fabian Schumacher, et al.Neuro-Signals|September 5, 2017
Targeting the Potassium Channel Kv1.3 Kills Glioblastoma CellsElisa Venturini, Luigi Leanza, Michele Azzolini, et al.Frontiers in Microbiology|August 20, 2025
Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1Isabel Zydek, Laura Thümmler, Nadine Beckmann, et al.Cancers|April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaStephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.Journal of Molecular Medicine (Berlin, Germany)|January 25, 2015
Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsisHuiming Peng, Cao Li, Stephanie Kadow, et al.Biological Chemistry|June 17, 2018
Pathological manifestations of Farber disease in a new mouse modelNadine Beckmann, Stephanie Kadow, Fabian Schumacher, et al.Journal of Molecular Medicine (Berlin, Germany)|February 15, 2023
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivoSameer H Patel, Magdalena Bachmann, Stephanie Kadow, et al.Viruses|April 27, 2024
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsLaura Thümmler, Nadine Beckmann, Carolin Sehl, et al.Redox Biology|October 2, 2020
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the familyRoberta Peruzzo, Andrea Mattarei, Michele Azzolini, et al.Pageof 3